STOCK TITAN

Enovis (ENOV) director Shirley Brady receives 9,346-share stock grant, holds 110,589

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Shirley Brady reported acquisition or exercise transactions in this Form 4 filing.

Enovis CORP director Shirley Brady received a grant of 9,346 shares of common stock on May 19, 2026. The shares were awarded at no stated price as compensation rather than a market purchase. After this award, Brady directly holds a total of 110,589 Enovis common shares.

Positive

  • None.

Negative

  • None.

Insights

Director received routine stock grant, increasing direct stake modestly.

Director Shirley Brady was granted 9,346 shares of Enovis CORP common stock as a compensation award, not an open-market purchase. The filing shows no associated sales or derivative exercises, indicating a straightforward equity grant.

Following the grant, Brady directly holds 110,589 common shares. This type of award is a common board compensation tool and, based on the data provided, represents a modest increase in her ownership rather than a large, thesis-changing transaction.

Insider Shirley Brady
Role null
Type Security Shares Price Value
Grant/Award Common stock, par value $0.001 9,346 $0.00 --
Holdings After Transaction: Common stock, par value $0.001 — 110,589 shares (Direct, null)
Footnotes (1)
Shares granted 9,346 shares Common stock grant on May 19, 2026
Grant price $0.00 per share Recorded price for stock award
Shares owned after 110,589 shares Total direct holdings following transaction
Transaction code A Grant, award, or other acquisition of common stock
Common stock, par value $0.001 financial
"security_title: Common stock, par value $0.001"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
transaction_code "A" regulatory
"transaction_code: "A""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shirley Brady

(Last)(First)(Middle)
2711 CENTERVILLE ROAD
SUITE 400

(Street)
WILMINGTON DELAWARE 19808

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock, par value $0.00105/19/2026A9,346A$0.00110,589D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Brian P. Hanigan, attorney-in-fact05/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Enovis (ENOV) director Shirley Brady report?

Enovis director Shirley Brady reported receiving a grant of 9,346 shares of common stock. The award was recorded at a price of $0.00 per share, reflecting a compensation grant rather than an open-market purchase, and increased her direct shareholdings in the company.

How many Enovis (ENOV) shares does Shirley Brady own after this Form 4?

After the reported grant, Shirley Brady directly holds 110,589 shares of Enovis common stock. This total reflects her position following the award of 9,346 shares on May 19, 2026, and shows her ongoing equity exposure as a board member of the company.

Was the Enovis (ENOV) Form 4 transaction a stock purchase or a grant?

The Form 4 reports a stock grant, not a market purchase. Transaction code "A" and a $0.00 per-share price indicate a “grant, award, or other acquisition” of 9,346 Enovis common shares provided as compensation rather than shares bought in the open market.

Does the Enovis (ENOV) Form 4 show any stock sales by Shirley Brady?

The filing shows no stock sales by Shirley Brady. It reports only one acquisition transaction: a grant of 9,346 Enovis common shares. Transaction summaries list no sell, exercise, gift, or tax-withholding entries, indicating no dispositions in this particular Form 4.

Is the Enovis (ENOV) insider transaction part of an options exercise?

No option exercise is shown in this Form 4. The transaction is coded "A" as a direct grant or award of 9,346 common shares, with derivative transaction counts listed as zero, indicating no option, warrant, or other derivative exercises in this disclosure.

How significant is Shirley Brady’s Enovis (ENOV) stock grant for investors?

The grant increases Shirley Brady’s direct holdings to 110,589 shares, but remains a typical director equity award. It reflects ongoing alignment between board compensation and shareholder interests, without indicating a large discretionary buy or sell decision that would materially shift investor views.